Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Anergen Inc
Profile last edited on: 5/1/08      CAGE:       UEI:

Business Identifier: Proprietary Drug Products
Year Founded
1988
First Award
1998
Latest Award
1998
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

301 Penobscot Drive
Redwood City, CA 94063
   (650) 361-8901
   bsherman@anergen.com
   www.anergen.com
Location: Single
Congr. District: 14
County: San Mateo

Public Profile

Anergen has developed therapeutics for autoimmune disease using biopharmaceutical compounds that are designed to inactivte specific T cells in the immune system. Anergen, Inc. was acquired by Corixa Corporation on February 12, 1999

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$296,812
Phase II Dollars
$0
Total Awarded
$296,812

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1998 1 NIH $100,000
Project Title: Peptides for Myasthenia Gravis Therapy
1998 1 NIH $99,812
Project Title: Selective Control Of T Cell Migration In Type 1 Diabetes
1998 1 NIH $97,000
Project Title: Self Mhc Class Ii Beta Chain As Vaccine For Diabetes

Key People / Management

  Barry Sherman -- President

  Shrikant G Deshpande

  Maureen E Howard

  Eva-Pia E Reich

Company News

There are no news available.